In vivo assessment of NuvaRing® placement
- 30 September 2005
- journal article
- Published by Elsevier in Contraception
- Vol. 72 (3), 196-199
- https://doi.org/10.1016/j.contraception.2005.03.012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstetrics & Gynecology, 2002
- Use of MRI to determine the in vivo position of a silicone vaginal barrier contraceptive device☆Contraception, 2002
- Contraceptive Vaginal RingsSeminars in Reproductive Medicine, 2001
- Distribution of topical medication in the human vagina as imaged by magnetic resonance imagingFertility and Sterility, 2001
- Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibitionFertility and Sterility, 2001
- Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiolHuman Reproduction, 2001
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- Contraceptive Failure Rates: New Estimates from the 1995 National Survey of Family GrowthFamily Planning Perspectives, 1999
- Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytologyContraception, 1983
- The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal floraContraception, 1981